Barros, Eric
Novo Nordisk (Denmark)
2 papers on CoChatORCID 0000-0001-6613-4181
Most cited papers
- Verified
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial
Ryan, D. H., Lingvay, I., Deanfield, J., Kahn, S. E., Barros, E., Burguera, B., Colhoun, H. M., Cercato, C., Dicker, D., Horn, D. B., et al. (2024) · Nature Medicine
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 347
- Verified
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Borlaug, B. A., Kitzman, D. W., Davies, M. J., Rasmussen, S., Barros, E., Butler, J., Einfeldt, M. N., Hovingh, G. K., Møller, D. V., Petrie, M. C., et al. (2023) · Nature Medicine
Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors
Cited by 215
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free